Baseline clinical characteristics of each group: controls, mutation carriers without phenotype expression (Mut+/Phen−), and mutation carriers with phenotype expression (Mut+/Phen+).

Abbreviations: ACEI = angiotensin converting enzyme inhibitors; ARB = angiotensin receptor blocker; CCB = calcium channel blocker; MYBPC3 = myosin-binding protein C; MYH7 = β-myosin heavy chain.*Significant difference vs. controls and Mut+/Phen−.

缩写说明：ACEI即血管紧张素转换酶抑制剂（angiotensin converting enzyme inhibitors）；ARB即血管紧张素受体阻滞剂（angiotensin receptor blocker）；CCB即钙通道阻滞剂（calcium channel blocker）；MYBPC3即肌球蛋白结合蛋白C（myosin-binding protein C）；MYH7即β-肌球蛋白重链（β-myosin heavy chain）。*与对照组及Mut+/Phen−组存在显著差异。